FDG-PET Evaluation of Response to Treatment

被引：1
作者：
Kostakoglu, Lale [1 ]
机构：
[1] Mt Sinai Med Ctr, Dept Radiol, Div Nucl Med, One Gustave Levy Pl,Box 1141, New York, NY 10029 USA
来源：
PET CLINICS | 2008年 / 3卷 / 01期
关键词：
Therapy response; Anticancer therapy; PET; Prediction of response;
D O I：
10.1016/j.cpet.2008.09.001
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This article discusses evaluating response after and during therapy in various settings and for the types of cancers for which ample evidence demonstrates that PET imaging with flourodeoxyglucose provides a valuable surrogate for response to therapy. It also briefly discusses pitfalls in obtaining an optimal assessment of response and issues that need further attention for this modality to become established as an independent predictor of response to anticancer therapy.
引用
收藏
页码：37 / +
页数：41
相关论文
共 204 条
[11]   Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival [J].
Berger, AC ;
Farma, J ;
Scott, WJ ;
Freedman, G ;
Weiner, L ;
Cheng, JD ;
Wang, H ;
Goldberg, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4330-4337
[12]   [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy [J].
Berriolo-Riedinger, Alina ;
Touzery, Claude ;
Riedinger, Jean-Marc ;
Toubeau, Michel ;
Coudert, Bruno ;
Arnould, Laurent ;
Boichot, Christophe ;
Cochet, Alexandre ;
Fumoleau, Pierre ;
Brunotte, Francois .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (12) :1915-1924
[13]   Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin [J].
Blodgett, TM ;
Ames, JT ;
Torok, FS ;
McCook, BM ;
Meltzer, CC .
CLINICAL NUCLEAR MEDICINE, 2004, 29 (03) :161-163
[14]   Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography [J].
Bodet-Milin, Caroline ;
Kraeber-Bodere, Francoise ;
Dupas, Benoit ;
Morschhauser, Franck ;
Gastinne, Thomas ;
Le Gouill, Steven ;
Campion, Loic ;
Harousseau, Jean-Luc ;
Wegener, William A. ;
Goldenberg, David M. ;
Huglo, Damien .
HAEMATOLOGICA, 2008, 93 (03) :390-397
[15]   COPBLAM-III - INFUSIONAL COMBINATION CHEMOTHERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA [J].
BOYD, DB ;
COLEMAN, M ;
PAPISH, SW ;
TOPILOW, A ;
KOPEL, SK ;
BERNHARDT, B ;
FILES, JC ;
SCHWARTZ, S ;
GAYNOR, M ;
MCDERMOTT, D ;
REISMAN, AM ;
COLEMAN, BL .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :425-433
[16]   Hodgkin lymphoma: Response assessment by revised international workshop criteria [J].
Brepoels, Lieselot ;
Stroobants, Sigrid ;
De Wever, Walter ;
Spaepen, Karoline ;
Vandenberghe, Peter ;
Thomas, Jose ;
Uyttebroeck, Anne ;
Mortelmans, Luc ;
De Wolf-Peeters, Christiane ;
Verhoef, Gregor .
LEUKEMIA & LYMPHOMA, 2007, 48 (08) :1539-1547
[17]   Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by integrated international workshop criteria [J].
Brepoels, Lieselot ;
Stroobants, Sigrid ;
De Wever, Walter ;
Spaepen, Karoline ;
Vandenberghe, Peter ;
Thomas, Jose ;
Uyttebroeck, Anne ;
Mortelmans, Luc ;
De Wolf-Peeters, Christiane ;
Verhoef, Gregor .
LEUKEMIA & LYMPHOMA, 2007, 48 (08) :1522-1530
[18]  
Brepoels L, 2007, J NUCL MED, V48, P390
[19]  
Brown RS, 1999, J NUCL MED, V40, P556
[20]  
Brucher BLDM, 2001, ANN SURG, V233, P300
12345678910